| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
105,180 |
97,827 |
$12.19M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
100,095 |
94,291 |
$11.78M |
| S9083 |
Global fee urgent care centers |
60,924 |
54,836 |
$7.96M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
45,807 |
45,358 |
$5.39M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23,018 |
22,721 |
$2.69M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,908 |
1,908 |
$229K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,153 |
1,120 |
$113K |
| 99215 |
Prolong outpt/office vis |
864 |
855 |
$101K |
| 99205 |
Prolong outpt/office vis |
32 |
31 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,860 |
1,795 |
$45.23 |
| 71046 |
Radiologic examination, chest; 2 views |
200 |
200 |
$13.67 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25,484 |
23,758 |
$3.79 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,101 |
2,008 |
$0.00 |
| 73110 |
|
461 |
452 |
$0.00 |
| 73140 |
|
974 |
960 |
$0.00 |
| 73130 |
|
200 |
199 |
$0.00 |
| 81003 |
|
2,817 |
2,653 |
$0.00 |
| 81025 |
|
119 |
118 |
$0.00 |
| 73610 |
|
909 |
889 |
$0.00 |
| 12011 |
|
148 |
146 |
$0.00 |
| 73080 |
|
44 |
43 |
$0.00 |
| 73630 |
|
622 |
614 |
$0.00 |
| J7699 |
Noc drugs, inhalation solution administered through dme |
108 |
69 |
$0.00 |
| 29125 |
|
28 |
28 |
$0.00 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
12 |
12 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,344 |
2,265 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,091 |
2,041 |
$0.00 |
| 87428 |
|
665 |
657 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
6,700 |
3,805 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,311 |
1,283 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
142 |
142 |
$0.00 |
| Q4049 |
Finger splint, static |
30 |
29 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,501 |
1,468 |
$0.00 |
| 82962 |
|
91 |
88 |
$0.00 |
| 29540 |
|
118 |
116 |
$0.00 |
| 99024 |
|
43 |
40 |
$0.00 |
| 99000 |
|
17,051 |
16,198 |
$0.00 |
| 73090 |
|
13 |
13 |
$0.00 |
| 87807 |
|
55 |
54 |
$0.00 |
| 73560 |
|
12 |
12 |
$0.00 |